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E xtracorporeal membrane oxygenation (ECMO) has recently been used in the wider area of critical 
care for acute respiratory distress syndrome (ARDS).  
The introduction of ECMO is almost always an emer-
gency procedure in life-threatening conditions.  In con-
trast,  the timing of weaning from ECMO varies 
depending on the patient’s specific conditions.  During 
ECMO treatment for ARDS,  the concept of lung rest is 
also widely appreciated,  but there are still many diffi-
culties in assessing respiratory stress and the breathing 
workload,  especially in the process of weaning from 
ECMO.  In this assessment,  we conventionally use the 
parameters of the partial pressure of oxygen in the arte-
rial blood (PaO2),  the partial pressure of carbon dioxide 
(PaCO2),  the respiratory rate (RR) and the tidal volume 
(TV),  but it is difficult to evaluate respiratory reserve in 
the early stage of ECMO weaning.
The electrical activity of the diaphragm (EAdi) can 
indicate the global diaphragmatic activation and power 
output from the central nervous system (CNS),  and it is 
the driving source of neurally adjusted ventilatory assist 
(NAVA),  which is an assisted ventilatory mode that 
delivers proportional support.  Of note,  the EAdi is 
suggested to be an objective indicator of the patient’s 
own breathing effort [1].  The EAdi increases with the 
worsening of respiratory status,  reduced ventilator 
assist,  increased dead space,  and other ventilation 
problems.  Conversely,  respiratory improvement and 
adequate ventilator support decrease the EAdi [1].  In 
individuals without respiratory complications,  the nor-
mal range of the EAdi is a few μV during resting breath-
ing.  An advantage of the EAdi is that it can immedi-
ately reflect a patient’s breathing workload.  We have 
thus used the EAdi as a potential earlier indicator to 
evaluate the breathing workload in the process of wean-
ing from ECMO.
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The electrical activity of the diaphragm (EAdi) shows global diaphragmatic activation and power output from 
the central nervous system.  We measured the EAdi as an indicator of breathing workload in a 40-year-old man 
suffering from severe acute respiratory distress syndrome (ARDS) secondary to influenza pneumonia in the 
process of weaning from extracorporeal membrane oxygenation (ECMO).  Turning off the sweep gas flow 
immediately led to EAdi elevation,  followed by hypoxia.  The patient was successfully weaned from ECMO by 
reference to EAdi.  This is the first case report to suggest that EAdi monitoring might be useful for ARDS 
patients during ECMO weaning.
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Case Presentation
A 40-year-old Japanese man suffering from respira-
tory failure with influenza type A was transferred to our 
ICU for the consideration of ECMO therapy for his 
refractory hypoxemia.  On admission to the ICU,  he 
was already intubated and supported by pressure sup-
port ventilation with an inspiratory fraction of oxygen 
(FIO2) of 0.9,  positive end-expiratory pressure (PEEP) 
of 26 cmH2O,  and pressure support (PS) of 4 cmH2O,  
because of his strong breathing effort.  Arterial blood 
gas analysis suggested severe hypoxia and metabolic 
acidosis (pH 7.39; PaO2,  68 mmHg; SaO2,  93%; PaCO2,  
34 mmHg; HCO3−,  20 mmol/L; lactate,  2.9 mmol/L).  
A chest X-ray and computed tomography showed bilat-
eral diffuse opacities (Fig. 1).  Cardiac ultrasound 
showed that his cardiac function was normal.  We made 
a diagnosis of severe ARDS secondary to influenza viral 
pneumonia,  which was later found to be H1N1 influ-
enza virus by the polymerase chain reaction (PCR) 
method.  Peramivir was administered for 5 days after an 
attack of fever > 40°C.
Since his PaO2/FIO2 ratio (P/F) was only 75 with the 
Murray score of 3.7 and his cardiac function was nor-
mal with no CNS damage,  we established veno-venous 
ECMO via bilateral femoral veins with 25-Fr cannulas.  
The ECMO session was initiated with a extracorporeal 
blood flow of approx.  4 L/min and a sweep gas flow of 
4 L/min with 100% oxygen (centrifugal pump,  
CAPIOX® SP101 PLUS; oxygenator,  CAPIOX® LX;  
Terumo,  Tokyo).  Anticoagulation therapy with unfrac-
tionated heparin was initiated to maintain an activated 
clotting time > 150 sec.
After the induction of ECMO therapy,  we adminis-
tered sedatives,  analgesics and neuromuscular blocking 
agents (propofol at 4 mg/kg/h,  fentanyl at 2 μg/kg/h,  
and rocuronium at 7 μg/kg/min) and conducted lung 
rest (FIO2 of 0.4,  PEEP of 15 cmH2O,  and plateau pres-
sure of 25 cmH2O).  At that time,  the patient’s TV was 
around 4 ml/kg of predicted body weight (PBW).  On 
the 4th day of ECMO therapy,  his oxygenation had 
improved to a P/F ratio of 330 under pressure con-
trol-synchronized intermittent mandatory ventilation 
(PC-SIMV) with the PEEP of 15 cmH2O,  plateau pres-
sure of 27 cmH2O,  and PS of 10 cmH2O above PEEP.  
We then ceased the administration of the neuromuscu-
lar blocking agent and tried to wean the patient from the 
ECMO.  However,  the first trial failed because his oxy-
genation worsened (P/F 60) again with strong sponta-
neous breathing; the RR was 25 breaths/min and TV 
was approx.  12 ml/kg of PBW under PC-SIMV with 
the PEEP of 15 cmH2O and the plateau pressure of 
23 cmH2O.
We therefore decided to continue the ECMO therapy 
again and also administered a neuromuscular blocking 
agent.  We performed bronchoalveolar lavage,  and 
there was no detection of influenza virus by PCR and no 
sign of bacterial infection.  We concluded that high 
transpulmonary pressure due to the patient’s increased 
breathing effort contributed to the lung injury.  Nine 
days later,  his oxygenation recovered to a P/F ratio of 
> 300 under PC-SIMV with the PEEP of 13 cmH2O and 
the plateau pressure of 25 cmH2O,  and we decided to 
attempt a second weaning trial.
In order to deliver proportional support and assess 
the patient’s breathing effort,  we applied a NAVA mode 
with EAdi monitoring (Servo-I; Maquet Critical Care,  
Solna,  Sweden) before the process of weaning from 
ECMO.  A NAVA catheter was inserted nasally to a 
length of 65 cm guided by an electrocardiogram,  and 
the appropriate position was confirmed by a chest 
X-ray.  The EAdi peak value was approx.  6 μV under 
ECMO with a sweep gas flow of 3 L/min and PC-SIMV 
with the PEEP of 13 cmH2O and the plateau pressure of 
25 cmH2O.  At the second weaning trial,  turning off the 
sweep gas flow immediately led to an increase in the 
EAdi to > 15 μV.  After that,  we observed that the 
patient’s oxygenation slowly decreased to a P/F ratio of 
< 150 in 20 min.  We therefore stopped this weaning 
trial.
Following the return to the previous sweep gas flow,  
the EAdi peak value immediately decreased again to 
approx.  6 μV (Table 1).  As we considered the patient’s 
condition to be premature for weaning,  we raised the 
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Fig.  1　 Chest X-ray and computed tomography scan on admis-
sion.  The diﬀuse opacity and nearly complete consolidation of both 
lungs at the level of the heart are apparent.
PEEP to 15 cmH2O and achieved a negative fluid bal-
ance of −2,000 ml for 3 days.  Two days later,  the 
patient’s EAdi was maintained at < 10 μV at the third 
weaning trial,  and he was successfully weaned from 
ECMO with enough oxygenation (P/F ratio > 300) and 
the elimination of carbon dioxide by using the NAVA 
mode (the PEEP of 15 cmH2O and NAVA level of 
1.0 cmH2O/μV) on the 15th day (Table 1).  As a result of 
gradual PEEP titration,  the patient was finally extu-
bated on the 19th day and he was discharged from the 
hospital without any disability on the 42nd day.
Discussion
We treated a patient who suffered from severe ARDS 
secondary to influenza pneumonia with ECMO and 
NAVA.  We monitored his EAdi under special circum-
stances that included ECMO weaning,  and we observed 
that the EAdi immediately reacted to the patient’s respi-
ratory status ahead of conventional parameters.
ECMO was shown to be an effective treatment for 
severe ARDS in an earlier study [2] that suggested 
inception criteria for ECMO therapy and recom-
mended ventilator settings during ECMO.  However,  
there has been no detailed description about ECMO 
weaning.  According to the Extracorporeal Life Support 
Organization guidelines,  the procedure for a trial to 
wean a patient from veno-venous (VV) ECMO is as 
follows: “When the sweep gas is stopped and the oxy-
genator is capped off,  we should check SaO2 and PaCO2 
at acceptable ventilator settings for an hour or more and 
afterwards make sure whether withdrawing from 
ECMO for patients is possible and adequate or not.” 
Difficulties in assessing respiratory stress and the 
breathing workload during ECMO weaning are often 
encountered.  Conventional parameters such as arterial 
blood gas data,  RR and measured values on ventilation 
must be assessed,  but they are sometimes insufficient 
for use as early indicators.
As a new mode of mechanical ventilation,  the recent 
introduction of NAVA has provided us with the oppor-
tunity to use the EAdi to evaluate the central respiratory 
drive.  The beneficial point of applying the EAdi is that 
we can simply confirm a real-time respiratory status 
without any complicated procedure.  Sinderby suggested 
that the EAdi showed a few μV in patients without respi-
ratory complications during resting breathing and that 
the EAdi increased with forced breathing [1].  The EAdi 
has been reported to be a perceptive indicator of 
breathing workload in not only healthy subjects but also 
patients with respiratory failure [3 , 4].  Several studies 
reported that the EAdi predicted weaning failure from 
mechanical ventilation earlier than other parameters 
[5-7].  The EAdi in patients who were not successfully 
weaned from the ventilator was significantly higher than 
that in patients with successful weaning.  According to 
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Table 1　 The changes in the electrical activity of the diaphragm (EAdi),  arterial blood gas data and ventilator variables at the 2nd and 
3rd ECMO weaning trials
2nd weaning trial 3rd weaning trial
Pre 10 min 20 min Return to ECMO Pre 10 min 20 min
Turn oﬀ 
ECMO
ECMO blood ﬂow (L/min) 2.6 2.6 2.6 2.6 1.5 1.5 1.5 0
ECMO sweep gas ﬂow (L/min) 3 0 0 3 3 0 0 0
EAdi peak (μV) 6.2 15.8 14.6 5.8 4.0 6.2 6.8 7.2
pH 7.423 7.441 7.465 7.401 7.419 7.408
PaO2/FIO2 ratio 205 131 255 281 359 322
PaCO2 (mmHg) 46.3 45 44.2 44.2 40.1 39
Tidal Volume (ml) 435 560 535 416 370 451 503 480
Respiratory rate (/min) 12 14 16 10 14 16 18 20
PEEP (cmH2O) 13 13 13 13 15 15 15 15
At the 2nd weaning trial,  turning oﬀ the sweep gas ﬂow immediately led to elevation of the EAdi (>15 μV) ahead of a decreased P/F ratio 
(<150).  We therefore stopped the weaning trial.  At the 3rd weaning trial,  the EAdi could be maintained at<10 μV with enough oxygen-
ation and the elimination of carbon dioxide,  and the patient was successfully weaned from ECMO.  
ECMO: extracorporeal membrane oxygenation,  PEEP: positive end-expiratory pressure.
these results,  the EAdi could be used as an earlier 
indicator of breathing workload on weaning from a 
ventilator.
Our patient’s excessive breathing effort induced high 
transpulmonary pressure,  which could have resulted in 
the respiratory deterioration observed on his first trial of 
weaning from ECMO.  The stronger his breathing 
workload became,  the higher his EAdi value became.  
Bellani et al.  reported that the EAdi was closely related 
to the esophageal pressure,  which was suggested to 
reflect the patient’s transpulmonary pressure and could 
be used to estimate the inspiratory effort [4].
The data regarding the EAdi and NAVA during 
ECMO therapy are limited.  NAVA was reported to 
reduce asynchrony in ARDS patients with very low 
compliance during or after ECMO [8 , 9].  However,  
there is little informaton about evaluations of the EAdi 
in the process of weaning from ECMO as in the present 
patient’s case.  Karagiannidis et al.  reported that the 
combination of extracorporeal lung support and NAVA 
was a plausible and sensible complementary application 
of two different techniques in patients with severe lung 
failure [10].  They showed that the EAdi and NAVA led 
to better synchrony and autoregulation during ECMO,  
but they did not describe readiness for weaning from 
ECMO.
In our patient’s case,  we used the EAdi in addition to 
other respiratory parameters such as the PaO2,  PaCO2,  
RR,  TV as indicators of respiratory stress during the 
weaning trials.  At the second failed weaning trial,  
turning off the sweep gas flow led to the elevation of the 
EAdi (> 15 μV),  followed by hypoxia.  After the modu-
lation of ventilator settings and fluid balance,  at the 
third weaning trial,  the EAdi could be maintained at 
< 10 μV,  which was lower than the previous trial and 
which had been considered to indicate stable respiratory 
effort in some reports [1 , 6].  As a result,  the patient 
was successfully weaned from ECMO with enough oxy-
genation and the elimination of carbon dioxide.  
Considering these results,  we speculated that the EAdi 
could be used to assess respiratory reserve earlier than 
other parameters.
Although there is no definite cutoff point at this 
time,  EAdi monitoring in the process of weaning from 
ECMO might be useful as in weaning from mechanical 
ventilation to monitor patients’ spontaneous breathing 
workload.  Additional clinical research is needed to 
confirm the utility of the EAdi as an indicator of breath-
ing workload.
In conclusion,  we have reported a case of ARDS 
treated with ECMO in which EAdi monitoring was used 
for weaning from ECMO for the first time.  In this case,  
the EAdi reacted to the patient’s respiratory status ear-
lier than other respiratory parameters in the process of 
weaning from ECMO.  The EAdi might thus be worth-
while to use for patients during ECMO weaning.
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